Logo image of VCEL

VERICEL CORP (VCEL) Stock Fundamental Analysis

NASDAQ:VCEL - Nasdaq - US92346J1088 - Common Stock - Currency: USD

52  -2.31 (-4.25%)

After market: 52 0 (0%)

Fundamental Rating

5

Taking everything into account, VCEL scores 5 out of 10 in our fundamental rating. VCEL was compared to 572 industry peers in the Biotechnology industry. VCEL has only an average score on both its financial health and profitability. VCEL is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

VCEL had positive earnings in the past year.
In the past year VCEL had a positive cash flow from operations.
VCEL had negative earnings in 4 of the past 5 years.
VCEL had a positive operating cash flow in 4 of the past 5 years.
VCEL Yearly Net Income VS EBIT VS OCF VS FCFVCEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

1.2 Ratios

The Return On Assets of VCEL (0.91%) is better than 93.25% of its industry peers.
Looking at the Return On Equity, with a value of 1.38%, VCEL belongs to the top of the industry, outperforming 93.78% of the companies in the same industry.
Industry RankSector Rank
ROA 0.91%
ROE 1.38%
ROIC N/A
ROA(3y)-3.36%
ROA(5y)-3%
ROE(3y)-4.83%
ROE(5y)-4.21%
ROIC(3y)N/A
ROIC(5y)N/A
VCEL Yearly ROA, ROE, ROICVCEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60 -80 -100

1.3 Margins

VCEL's Profit Margin of 1.56% is amongst the best of the industry. VCEL outperforms 93.43% of its industry peers.
VCEL's Gross Margin of 71.47% is amongst the best of the industry. VCEL outperforms 83.48% of its industry peers.
In the last couple of years the Gross Margin of VCEL has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 1.56%
GM 71.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.41%
GM growth 5Y1.23%
VCEL Yearly Profit, Operating, Gross MarginsVCEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

VCEL does not have a ROIC to compare to the WACC, probably because it is not profitable.
VCEL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for VCEL has been increased compared to 5 years ago.
VCEL has a worse debt/assets ratio than last year.
VCEL Yearly Shares OutstandingVCEL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
VCEL Yearly Total Debt VS Total AssetsVCEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

VCEL has an Altman-Z score of 11.65. This indicates that VCEL is financially healthy and has little risk of bankruptcy at the moment.
VCEL has a better Altman-Z score (11.65) than 87.74% of its industry peers.
VCEL has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
VCEL has a Debt to Equity ratio (0.00) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.65
ROIC/WACCN/A
WACC9.45%
VCEL Yearly LT Debt VS Equity VS FCFVCEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

VCEL has a Current Ratio of 4.61. This indicates that VCEL is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 4.61, VCEL perfoms like the industry average, outperforming 50.80% of the companies in the same industry.
VCEL has a Quick Ratio of 4.23. This indicates that VCEL is financially healthy and has no problem in meeting its short term obligations.
VCEL's Quick ratio of 4.23 is in line compared to the rest of the industry. VCEL outperforms 50.09% of its industry peers.
Industry RankSector Rank
Current Ratio 4.61
Quick Ratio 4.23
VCEL Yearly Current Assets VS Current LiabilitesVCEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

8

3. Growth

3.1 Past

VCEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 126.09%, which is quite impressive.
VCEL shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.48%.
VCEL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.79% yearly.
EPS 1Y (TTM)126.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)22.48%
Revenue growth 3Y16.72%
Revenue growth 5Y16.79%
Sales Q2Q%27.04%

3.2 Future

VCEL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 85.18% yearly.
VCEL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.72% yearly.
EPS Next Y254.42%
EPS Next 2Y165.13%
EPS Next 3Y128.53%
EPS Next 5Y85.18%
Revenue Next Year21.31%
Revenue Next 2Y21.45%
Revenue Next 3Y22.76%
Revenue Next 5Y23.72%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VCEL Yearly Revenue VS EstimatesVCEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
VCEL Yearly EPS VS EstimatesVCEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

VCEL is valuated quite expensively with a Price/Earnings ratio of 866.67.
Based on the Price/Earnings ratio, VCEL is valued cheaper than 92.18% of the companies in the same industry.
VCEL's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.63.
VCEL is valuated quite expensively with a Price/Forward Earnings ratio of 114.89.
Based on the Price/Forward Earnings ratio, VCEL is valued cheaply inside the industry as 90.94% of the companies are valued more expensively.
VCEL is valuated expensively when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 866.67
Fwd PE 114.89
VCEL Price Earnings VS Forward Price EarningsVCEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600 800

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VCEL indicates a rather cheap valuation: VCEL is cheaper than 92.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 640.81
VCEL Per share dataVCEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VCEL does not grow enough to justify the current Price/Earnings ratio.
VCEL's earnings are expected to grow with 128.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.41
PEG (5Y)N/A
EPS Next 2Y165.13%
EPS Next 3Y128.53%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VCEL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VERICEL CORP

NASDAQ:VCEL (2/21/2025, 8:00:01 PM)

After market: 52 0 (0%)

52

-2.31 (-4.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-27 2025-02-27/bmo
Inst Owners107.75%
Inst Owner Change5.12%
Ins Owners0.97%
Ins Owner Change3.39%
Market Cap2.57B
Analysts87.14
Price Target67.83 (30.44%)
Short Float %7.69%
Short Ratio10.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)21.8%
Min EPS beat(2)-16.02%
Max EPS beat(2)59.63%
EPS beat(4)3
Avg EPS beat(4)30.46%
Min EPS beat(4)-16.02%
Max EPS beat(4)59.63%
EPS beat(8)6
Avg EPS beat(8)52.07%
EPS beat(12)6
Avg EPS beat(12)22.09%
EPS beat(16)8
Avg EPS beat(16)-4.24%
Revenue beat(2)1
Avg Revenue beat(2)0.51%
Min Revenue beat(2)-1.82%
Max Revenue beat(2)2.84%
Revenue beat(4)2
Avg Revenue beat(4)0.56%
Min Revenue beat(4)-1.82%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)1.48%
Revenue beat(12)5
Avg Revenue beat(12)-0.03%
Revenue beat(16)7
Avg Revenue beat(16)-0.1%
PT rev (1m)0%
PT rev (3m)12.44%
EPS NQ rev (1m)4.4%
EPS NQ rev (3m)3.72%
EPS NY rev (1m)10.1%
EPS NY rev (3m)27.17%
Revenue NQ rev (1m)-1.83%
Revenue NQ rev (3m)-3.61%
Revenue NY rev (1m)-0.6%
Revenue NY rev (3m)-0.56%
Valuation
Industry RankSector Rank
PE 866.67
Fwd PE 114.89
P/S 11.31
P/FCF N/A
P/OCF 55.8
P/B 9.97
P/tB 10.22
EV/EBITDA 640.81
EPS(TTM)0.06
EY0.12%
EPS(NY)0.45
Fwd EY0.87%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)0.93
OCFY1.79%
SpS4.6
BVpS5.22
TBVpS5.09
PEG (NY)3.41
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.91%
ROE 1.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.56%
GM 71.47%
FCFM N/A
ROA(3y)-3.36%
ROA(5y)-3%
ROE(3y)-4.83%
ROE(5y)-4.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.41%
GM growth 5Y1.23%
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.06
Cap/Depr 1120.29%
Cap/Sales 25.58%
Interest Coverage N/A
Cash Conversion 1164.61%
Profit Quality N/A
Current Ratio 4.61
Quick Ratio 4.23
Altman-Z 11.65
F-Score5
WACC9.45%
ROIC/WACCN/A
Cap/Depr(3y)350.53%
Cap/Depr(5y)262.54%
Cap/Sales(3y)7.87%
Cap/Sales(5y)5.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)126.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y254.42%
EPS Next 2Y165.13%
EPS Next 3Y128.53%
EPS Next 5Y85.18%
Revenue 1Y (TTM)22.48%
Revenue growth 3Y16.72%
Revenue growth 5Y16.79%
Sales Q2Q%27.04%
Revenue Next Year21.31%
Revenue Next 2Y21.45%
Revenue Next 3Y22.76%
Revenue Next 5Y23.72%
EBIT growth 1Y90.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year648.37%
EBIT Next 3Y134.71%
EBIT Next 5Y74.65%
FCF growth 1Y-187.15%
FCF growth 3Y-19.48%
FCF growth 5YN/A
OCF growth 1Y116.38%
OCF growth 3Y26.2%
OCF growth 5YN/A